Stryker Current Ratio 2006-2018 | SYK

Current and historical current ratio for Stryker (SYK) from 2006 to 2018. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Stryker current ratio for the three months ending December 31, 2018 was 2.03.
Stryker Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2018-12-31 $9.73B $4.81B 2.03
2018-09-30 $7.92B $4.15B 1.91
2018-06-30 $7.41B $4.05B 1.83
2018-03-31 $7.85B $4.80B 1.64
2017-12-31 $7.99B $3.49B 2.29
2017-09-30 $7.71B $3.26B 2.37
2017-06-30 $8.48B $3.55B 2.39
2017-03-31 $7.89B $2.55B 3.09
2016-12-31 $7.86B $3.15B 2.50
2016-09-30 $7.37B $3.03B 2.43
2016-06-30 $7.82B $3.61B 2.17
2016-03-31 $11.33B $3.19B 3.56
2015-12-31 $7.94B $3.50B 2.27
2015-09-30 $8.03B $3.55B 2.26
2015-06-30 $8.94B $3.72B 2.40
2015-03-31 $8.73B $3.70B 2.36
2014-12-31 $8.68B $4.46B 1.95
2014-09-30 $9.33B $4.21B 2.22
2014-06-30 $9.38B $3.71B 2.53
2014-03-31 $8.45B $3.56B 2.37
2013-12-31 $8.34B $2.66B 3.14
2013-09-30 $9.19B $2.32B 3.95
2013-06-30 $8.69B $1.97B 4.41
2013-03-31 $8.42B $1.81B 4.66
2012-12-31 $8.15B $1.88B 4.34
2012-09-30 $7.64B $1.58B 4.85
2012-06-30 $7.20B $1.49B 4.83
2012-03-31 $7.23B $1.55B 4.67
2011-12-31 $7.21B $1.84B 3.92
2011-09-30 $6.93B $1.56B 4.44
2011-06-30 $6.50B $1.60B 4.06
2011-03-31 $6.50B $1.59B 4.10
2010-12-31 $7.63B $1.61B 4.76
2010-09-30 $7.54B $1.41B 5.37
2010-06-30 $6.90B $1.30B 5.33
2010-03-31 $6.88B $1.41B 4.89
2009-12-31 $5.85B $1.44B 4.06
2009-09-30 $5.76B $1.20B 4.81
2009-06-30 $5.24B $1.08B 4.87
2009-03-31 $5.00B $1.18B 4.23
2008-12-31 $4.98B $1.46B 3.41
2008-09-30 $4.99B $1.14B 4.37
2008-06-30 $5.36B $1.12B 4.76
2008-03-31 $5.06B $1.15B 4.41
2007-12-31 $4.91B $1.33B 3.68
2007-09-30 $4.44B $1.09B 4.08
2007-06-30 $4.06B $1.04B 3.91
2007-03-31 $3.70B $1.06B 3.48
2006-12-31 $3.53B $1.35B 2.62
2006-09-30 $3.12B $1.11B 2.80
2006-06-30 $2.86B $1.06B 2.71
2006-03-31 $2.82B $1.13B 2.49
2005-12-31 $2.87B $1.25B 2.30
2005-09-30 $2.37B $1.04B 2.28
2005-06-30 $2.17B $0.95B 2.28
2005-03-31 $2.08B $0.95B 2.19
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $69.927B $13.601B
Stryker Corporation is one of the world's leading medical technology companies and together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $132.673B 26.23
Medtronic (MDT) Ireland $124.635B 18.20
Boston Scientific (BSX) United States $55.591B 27.10
Baxter (BAX) United States $39.448B 24.31
Zimmer Biomet Holdings (ZBH) United States $25.289B 16.23
Smith & Nephew SNATS (SNN) United Kingdom $16.755B 0.00
ResMed (RMD) United States $14.297B 27.11
Canopy Growth (CGC) Canada $10.742B 0.00
Bio-Rad Laboratories (BIO) United States $8.172B 52.25
Aurora Cannabis (ACB) Canada $7.060B 50.50
Hill-Rom Holdings (HRC) United States $6.958B 21.52
Perrigo (PRGO) Ireland $6.649B 10.09
ICU Medical (ICUI) United States $5.184B 28.88
Insulet (PODD) United States $5.071B 0.00
Haemonetics (HAE) United States $4.540B 40.28
GW Pharmaceuticals (GWPH) United Kingdom $4.400B 0.00
Agios Pharmaceuticals (AGIO) United States $3.380B 0.00
Hutchison China MediTech (HCM) China $3.329B 0.00
Neogen (NEOG) United States $3.267B 50.18
NuVasive (NUVA) United States $2.850B 24.96
Quidel (QDEL) United States $2.761B 24.91
National Vision Holdings (EYE) United States $2.637B 51.01
Aphria (APHA) $2.539B 112.78
NxStage Medical (NXTM) United States $2.000B 0.00
AtriCure (ATRC) United States $1.274B 0.00
HEXO (HEXO) $1.242B 0.00
Cardiovascular Systems (CSII) United States $1.240B 890.25
Phibro Animal Health (PAHC) United States $1.220B 17.53
VAREX IMAGING (VREX) United States $1.212B 23.73
MacroGenics (MGNX) United States $0.939B 0.00
Cerus (CERS) United States $0.904B 0.00
PetIQ (PETQ) United States $0.867B 22.47
Lantheus Holdings (LNTH) United States $0.847B 22.95
Surmodics (SRDX) United States $0.785B 114.20
Meridian Bioscience (VIVO) United States $0.733B 21.85
NanoString Technologies (NSTG) United States $0.721B 0.00
OraSure Technologies (OSUR) United States $0.720B 31.76
Omeros (OMER) United States $0.719B 0.00
Evolus (EOLS) United States $0.705B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.647B 20.75
LeMaitre Vascular (LMAT) United States $0.603B 28.76
Quanterix (QTRX) United States $0.518B 0.00
Insys Therapeutics (INSY) United States $0.426B 0.00
Owens & Minor (OMI) United States $0.408B 5.65
TG Therapeutics (TGTX) United States $0.398B 0.00
Utah Medical Products (UTMD) United States $0.339B 21.99
BioLife Solutions (BLFS) United States $0.329B 445.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.294B 0.00
Vapotherm (VAPO) United States $0.288B 0.00
Bovie Medical (APYX) United States $0.282B 0.00
Rockwell Medical (RMTI) United States $0.262B 0.00
Cytosorbents (CTSO) United States $0.256B 0.00
Zynex (ZYXI) United States $0.174B 16.84
Fonar (FONR) United States $0.144B 7.70
Surface Oncology (SURF) United States $0.140B 0.00
Chembio Diagnostics (CEMI) United States $0.112B 0.00
Chimerix (CMRX) United States $0.100B 0.00
United-Guardian (UG) United States $0.090B 18.77
Female Health (VERU) United States $0.084B 0.00
InfuSystems Holdings (INFU) United States $0.078B 0.00
CAS Medical Systems (CASM) United States $0.070B 0.00
Trinity Biotech (TRIB) Ireland $0.066B 18.20
Conatus Pharmaceuticals (CNAT) United States $0.057B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.056B 0.00
ImmuCell (ICCC) United States $0.038B 0.00
Neurotrope (NTRP) United States $0.034B 0.00
Senestech (SNES) United States $0.021B 0.00
Myomo (MYO) United States $0.016B 0.00
Akers Biosciences Inc (AKER) United States $0.014B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.014B 0.00
Capricor Therapeutics (CAPR) United States $0.013B 0.00
Valeritas Holdings (VLRX) United States $0.010B 0.00
Cellectar Biosciences (CLRB) United States $0.010B 0.00
NeuroMetrix (NURO) United States $0.008B 14.14